Capitol Health Ltd (ASX:CAJ)
A$ 0.355 -0.01 (-2.74%) Market Cap: 389.34 Mil Enterprise Value: 509.11 Mil PE Ratio: 0 PB Ratio: 3.55 GF Score: 53/100

Half Year 2020 Capitol Health Ltd Earnings Call Transcript

Feb 25, 2020 / 11:00PM GMT
Release Date Price: A$0.285 (+7.55%)
Justin Samuel Walter
Capitol Health Limited - CEO, MD & Director

Good morning, everyone, and welcome to the Capitol Health Half Year Presentation this morning from myself, Justin Walter, the Managing Director, and I have with me, Marcell Judkins, our Chief Financial Officer.

So we'll get straight into the deck and move to the executive summary. So just running through each key achievements and the highlights for the half year. With our revenue confirmed solid organic growth while reshaping the portfolio for increased profitability. We've seen an increase in revenue of $8.2 million, representing 11% growth year-on-year. Our net debt remains at $44.5 million, which allows for the purchase of FSR to remain under our covenants of 2x the net debt ratio at a Board level. We continue our dividend policy with an interim dividend declared at $0.005 per share fully franked. In the half year, we had a further investment in Enlitic and continued support for that product development and eventual rollout through our business. And excitingly as well, we opened up our Cranbourne Greenfield, which is going

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot